AgenciesFosun Pharma holds a 57.86% stake in the Indian company. Both Fosun Pharma and Gland Pharma did not immediately respond to Reuters' requests for comment.
Shares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had reported, citing sources that Fosun Pharma was considering a sale of Gland Pharma after receiving interest from potential buyers.
(Reporting by Rama Venkat in Bengaluru; Editing by Rashmi Aich)
Wednesday, 26 Apr, 2023- Front Page
- Pure Politics
- Companies
- ET Markets
- More
- Macro Stability to Help Sustain Growth: Finmin
Increased macroeconomic stability has made India’s growth rate sustainable, the finance ministry said on Tuesday but called for vigilance against risks from El Nino-triggered drought conditions, geopolitical developments and global financial turmoil.
Airtel Weathered Storms to Emerge as Strong InstitutionBharti Airtel has overcome existential crises in 2003 (intense competition) and 2020 (Supreme Court’s AGR verdict) as well as the ‘tsunami’ of 2016 (Reliance Jio’s launch) to emerge as an institution that is a national asset, said chairman Sunil Mittal.
Vedanta Very Comfortable; Concerns Over its Debt Situation MisplacedVedanta Group chairman Anil Agarwal on Tuesday said Vedanta Resources (VRL), holding company of the mining and metals conglomerate, is well-positioned to meet its future debt obligations, and that concerns around the group being over-leveraged are misplaced.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
